Compounded by Promise Pharmacy | 503A

Compounded Tirzepatide with Glycine and B12 for Clinics

The enhanced Tirzepatide formulation with Glycine for injection site comfort and Methylcobalamin B12 for metabolic support. Compounded under 503A standards and shipped to clinics in 42 states.

Enhanced Combo Formula
24-72 hr Fulfillment
42 States
Direct Pricing
Overview

What Is the Tirzepatide + Glycine + B12 Combination?

This combination formulation pairs Tirzepatide (a dual GIP/GLP-1 receptor agonist) with Glycine and Methylcobalamin B12 in a single injectable vial. Glycine is included to improve injection site tolerance, which many patients report as a concern with GLP-1 and GIP agonist therapies. B12 provides metabolic support that complements the weight management protocol. This formulation has become one of the most popular GLP-1 compounds ordered through Promise Pharmacy.

Clinical Use

Why Clinics Prefer the Combination Formula

Many weight loss clinics have shifted from standalone Tirzepatide to the Glycine + B12 combination because it addresses two common patient concerns in one vial: injection site discomfort and metabolic nutrient support during caloric restriction. Prescribers report that patients on the combination formulation are more compliant with their injection schedule and experience fewer complaints about injection site reactions. The single-vial design also simplifies clinic inventory and reduces per-patient preparation time.

Formulations

Available Formulations from Promise Pharmacy

Formulation
Administration
Notes
Tirzepatide + Glycine + B12
Subcutaneous injection
Multiple concentrations for dose-escalation. Single-vial combination.
Why Promise

Why Clinics Order Tirzepatide + Glycine + B12 from Promise

Single-Vial Simplicity. One injection delivers the dual agonist plus supportive compounds. Less inventory, less prep, better compliance.High Patient Satisfaction. Clinics report fewer injection site complaints and stronger adherence with the Glycine-enhanced formula.In-Stock Availability. This is one of our highest-volume compounds. Consistent supply across all concentrations.Direct Pricing. No broker fees on any GLP-1 formulation, including combination compounds.

Frequently Asked Questions

Why add Glycine to Tirzepatide?

Glycine acts as a buffering amino acid that can improve injection site tolerance. Many clinics report reduced patient complaints about injection site reactions when using the Glycine-enhanced formulation.

Is this formulation more expensive than standalone Tirzepatide?

The combination is priced competitively. Contact your Promise account manager for current pricing across all Tirzepatide formulations.

advanced 503A COMPOUNDING

One Pharmacy, One
Portal, For Any Clinic

A single access point for a wide range of 503A formulary products, catering to the requirements of any medical clinic, med spa, or telehealth provider.

Meet Our Team of Compounding Experts

At Promise Pharmacy, our dedicated team of hormone health specialists is led by Amy Patel, a seasoned expert in sterile compounding with more than 25 years of experience.

Dee Patel, PharmD
CEO
Amy Patel, Rph
COO
Amar Patel
CFO
Mike Patel
CRO
Rikin Patel
Director of Operations
Jacki
Pharmacy Development Director
Matt Orban
Director of Partnerships
Honey Arias
Success Manager
Learn More About Us
AVAILABILITY

Where we serve

Available
Pending
Unavailable
Wisconsin
Available
Wyoming
Available
West Virginia
Available
Washington
Available
Virginia
Pending
Vermont
Available
Texas
Unavailable
Utah
Available
Tennessee
Available
South Dakota
Available
South Carolina
Unavailable
Rhode Island
Available
Oklahoma
Available
Oregon
Available
Pennsylvania
Available
Ohio
Available
North Carolina
Available
North Dakota
Available
New York
Available
New Mexico
Available
New Jersey
Available
New Hampshire
Available
Nebraska
Available
Nevada
Available
Missouri
Available
Montana
Available
Mississippi
Unavailable
Michigan
Available
Massachusetts
Available
Maryland
Available
Maine
Available
Minnesota
Unavailable
Louisiana
Unavailable
Kentucky
Available
Kansas
Available
Indiana
Available
Iowa
Available
Illinois
Available
Idaho
Available
Hawaii
Available
District of Columbia
Available
Delaware
Available
Connecticut
Available
Georgia
Available
Florida
Available
Alaska
Available
Colorado
Available
Arizona
Available
Alabama
Unavailable
Arkansas
Unavailable
California
Unavailable